Evaluation of the screening power of Cognitive Abilities Screening Instrument for probable Alzheimer's disease using voxel-based morphometry

Clinical Imaging

Volumn 36, Issue 1, 2012, Pages 46-53

  Mok, Greta S P ^a   Wu, Yi Ying ^b   Lu, Kun Mu ^c   Wu, Jay ^d   Chen, Liang Kuang ^c,e   Wu, Tung Hsin ^f  

^a UNIVERSITY OF MACAU   (Macao)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^d CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Alzheimer's disease; Cognitive Abilities Screening Instrument; Voxel based morphometry

Indexed keywords

GRADING; MAGNETIC RESONANCE IMAGING; MATERIALS TESTING; NEURODEGENERATIVE DISEASES;

ALZHEIMER'S DISEASE; COGNITIVE ABILITY; NORMAL CONTROLS; SCORING SYSTEMS; SCREENING INSTRUMENTS; SCREENING METHODS; SHORT TERM MEMORY; VOXEL-BASED MORPHOMETRY;

DIAGNOSIS;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; COGNITIVE ABILITIES SCREENING INSTRUMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ETHNIC GROUP; EVALUATION; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORIENTATION; PRIORITY JOURNAL; SCORING SYSTEM; SHORT TERM MEMORY; VOXEL BASED MORPHOMETRY;

EID: 84855407582     PISSN: 08997071     EISSN: 18734499     Source Type: Journal    
DOI: 10.1016/j.clinimag.2011.03.004     Document Type: Article

References (39)

1. Petrella J.R., Coleman R.E., Doraiswamy P.M. Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology 2003, 226:315-336.
2. Lehericy S., Marjanska M., Mesrob L., Sarazin M., Kinkingnehun S. Magnetic resonance imaging of Alzheimer's disease. Eur Radiol 2007, 17:347-362.
3. Forlenza O.F., Diniz B.S., Gattaz W.F. Diagnosis and biomarkers of predementia in Alzheimer's disease. BMC Medicine 2010, 8:89.
4. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
5. Small G.W., Rabins P.V., Barry P.P., et al. Diagnosis and treatment of Alzheimer disease and related disorders. JAMA 1997, 278:1363-1371.
6. Graves A.B., Larson E.B., Edland S.D., et al. Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state. The Kame project. Am J Epidemiol 1996, 144:760-771.
7. McCurry S.M., Edland S.D., Teri L., et al. The Cognitive Abilities Screening Instrument (CASI): data from a cohort of 2524 cognitively intact elderly. Int J Geriatr Psychiatry 1999, 14:882-888.
8. White L., Petrovitch H., Ross G.W., et al. Prevalence of dementia in older Japanese-American men in Hawaii: the Honolulu-Asia Aging Study. JAMA 1996, 276:955-960.
9. Yamada M., Sasaki H., Mimori Y., et al. Prevalence and risks of dementia in the Japanese population: RERF's adult health study Hiroshima subjects. Radiation effects research foundation. J Am Geriatr Soc 1999, 47:189-195.
10. Liu H.C., Fuh J.L., Wang S.J., et al. Prevalence and subtypes of dementia in a rural Chinese population. Alzheimer Dis Assoc Disord 1998, 12:127-134.
11. Tsai R.C., Lin K.N., Wu K.Y., Liu H.C. Improving the screening power of the Cognitive Abilities Screening Instrument, Chinese version. Dement Geriatr Cogn Disord 2004, 18:314-320.
12. Liu H.C., Teng E.L., Lin K.N., Chuang Y.Y., Wang P.N., Fuh J.L., Liu C.Y. Performance on the Cognitive Abilities Screening Instrument at different stages of Alzheimer's disease. Dement Geriatr Cogn Disord 2002, 13:244-248.
13. Liu H.C., Teng E.L., Chuang Y.Y., Lin K.N., Fuh J.L., Wang P.N. The Alzheimer's disease assessment scale: findings from a low-education population. Dement Geriatr Cogn Disord 2002, 13:21-26.
14. Liu H.C., Chou P., Lin K.N., et al. Assessing cognitive abilities and dementia in a predominantly illiterate population of older individuals in Kinmen. Psychol Med 1994, 24:763-770.
15. Lin K.N., Wang P.N., Liu C.Y., Chen W.T., Lee Y.C., Liu H.C. Cutoff scores of the Cognitive Abilities Screening Instrument, Chinese version in screening of dementia. Dement Geriatr Cogn Disord 2002, 14:176-182.
16. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
17. Teng E.L., Chui H.C. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987, 48:314-318.
18. Hasegawa K. The clinical assessment of dementia in the aged. A dementia screening scale for psychogeriatric patients. Aging in the eighties and beyond 1983, 207-218. Springer, New York. M. Bergener, U. Lehr, E. Lang, R. Schmitz (Eds.).
19. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. Neuroimage 2000, 11:805-821.
20. Wright I.C., McGuire P.K., Poline J.B., et al. A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia. Neuroimage 1995, 2:244-252.
21. Mechelli A., Price C.J., Friston K.J., Ashburner J. Voxel-based morphometry of the human brain: methods and applications. Curr Med Imaging Rev 2005, 1:1-9.
22. Karas G.B., Burton E.J., Rombouts S.A., et al. A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage 2003, 18:895-907.
23. Frisoni G.B., Testa C., Zorzan A., et al. Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry. J Neurol Neurosurg Psychiatry 2002, 73:657-664.
24. Baron J.C., Chételat G., Desgranges B., et al. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 2001, 14:298-309.
25. Waragai M., Okamura N., Furukawa K., et al. Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease. J Neurol Sci 2009, 285:100-108.
26. Functional Imaging Laboratory. Wellcome Department of Imaging Neuroscience. SPM5 Manual: The FIL Methods Group; 2005. Available from: http://www.fil.ion.ucl.ac.uk.
27. Ashburner J., Friston K.J. Nonlinear spatial normalization using basis functions. Hum Brain Mapp 1999, 7:254-266.
28. Ashburner J., Friston K.J. Unified segmentation. Neuroimage 2005, 26:839-851.
29. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001, 14:21-36.
30. Kawachi T., Ishii K., Sakamoto S., et al. Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease. Eur J Nucl Med Mol I 2006, 33:801-809.
31. Ishii K., Kawachi T., Sasaki H., et al. Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of Z score images. Am J Neuroradiol 2005, 26:333-340.
32. Busatto G.F., Diniz B.S., Zanetti M.V. Voxel-based morphometry in Alzheimer's disease. Expert Rev Neurother 2008, 8:1691-1702.
33. Xie S., Xiao J.X., Gong G.L., Zang Y.F., Wang Y.H., Wu H.K., Jiang X.X. Voxel-based detection of white matter abnormalities in mild Alzheimer disease. Neurology 2006, 66:1845-1849.
34. Busatto G.F., Garrido G.E., Almeida O.P., et al. A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer's disease. Neurobiol Aging 2003, 24:221-231.
35. Shiino A., Watanabe T., Maeda K., Kotani E., Akiguchi I., Matsuda M. Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease. Neuroimage 2006, 33:17-26.
36. Grossman M., McMillan C., Moore P., Ding L., Glosser G., Work M., et al. What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration. Brain 2004, 127:628-649.
37. Double K.L., Halliday G.M., Kril J.J., et al. Topography of brain atrophy during normal aging and Alzheimer's disease. Neurobiol Aging 1996, 17:513-521.
38. Van Hoesen G.W., Parvizi J., Chu C.C. Orbitofrontal cortex pathology in Alzheimer's disease. Cereb Cortex 2000, 10:243-251.
39. Guo X., Wang Z., Li K., et al. Voxel-based assessment of gray and white matter volumes in Alzheimer's disease. Neurosci Lett 2010, 468:146-150.